Search research articles
Contact Us
Filters
Showing results (101-110 of 182) with videos related to
Page
of 19
Sort By:
Cancer Research
|
October 17, 2008
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer
Jamie K Miller, David L Shattuck, Ellen Q Ingalla, et al.
Differentiation; Research in Biological Diversity
|
March 14, 2009
Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer
Suzana S Couto, Mei Cao, Paulo C Duarte, et al.
Cancer Cell
|
July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
Jianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Cancer Cell
|
September 20, 2005
The transcriptional repressor Snail promotes mammary tumor recurrence
Susan E Moody, Denise Perez, Tien-chi Pan, et al.
The American Journal of Pathology
|
September 6, 2002
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors
Andrea Rosner, Keiko Miyoshi, Esther Landesman-Bollag, et al.
Cancer Research
|
July 23, 2003
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
Cory Abate-Shen, Whitney A Banach-Petrosky, Xiaohui Sun, et al.
Plos Genetics
|
October 29, 2019
The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression
Adam Olson, Vien Le, Joseph Aldahl, et al.
ILAR Journal
|
December 12, 2018
Digital Microscopy, Image Analysis, and Virtual Slide Repository
Famke Aeffner, Hibret A Adissu, Michael C Boyle, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Adaptive selection of p53 mutation metaplastic phenotypes in estrogen-independent progression of ER+ tumors: A mechanism for acquired resistance to hormonal therapy
Hyeongsun Moon, Hidetoshi Mori, Jane Chen, et al.
Cancer Research
|
September 25, 2010
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2
Ekaterina V Kalashnikova, Alexey S Revenko, Abigael T Gemo, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 182) with videos related to
Sort By:
Page
of 19
Cancer Research
|
October 17, 2008
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer
Jamie K Miller, David L Shattuck, Ellen Q Ingalla, et al.
Differentiation; Research in Biological Diversity
|
March 14, 2009
Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer
Suzana S Couto, Mei Cao, Paulo C Duarte, et al.
Cancer Cell
|
July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
Jianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Cancer Cell
|
September 20, 2005
The transcriptional repressor Snail promotes mammary tumor recurrence
Susan E Moody, Denise Perez, Tien-chi Pan, et al.
The American Journal of Pathology
|
September 6, 2002
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors
Andrea Rosner, Keiko Miyoshi, Esther Landesman-Bollag, et al.
Cancer Research
|
July 23, 2003
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
Cory Abate-Shen, Whitney A Banach-Petrosky, Xiaohui Sun, et al.
Plos Genetics
|
October 29, 2019
The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression
Adam Olson, Vien Le, Joseph Aldahl, et al.
ILAR Journal
|
December 12, 2018
Digital Microscopy, Image Analysis, and Virtual Slide Repository
Famke Aeffner, Hibret A Adissu, Michael C Boyle, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Adaptive selection of p53 mutation metaplastic phenotypes in estrogen-independent progression of ER+ tumors: A mechanism for acquired resistance to hormonal therapy
Hyeongsun Moon, Hidetoshi Mori, Jane Chen, et al.
Cancer Research
|
September 25, 2010
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2
Ekaterina V Kalashnikova, Alexey S Revenko, Abigael T Gemo, et al.
Page
of 19